Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
idelalisib plus rituximab
.
Show all posts
Showing posts with label
idelalisib plus rituximab
.
Show all posts
Wednesday, October 16, 2013
Phase 3 study of idelalisibin reports positive results in CLL patients
›
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its Phase 3 study (Study 116) evaluating idelalisib in previously-treated chronic...
›
Home
View web version
